Ohio kicked off their medical cannabis sales on Wednesday, January 16, 2019. The state issued licenses for 56 dispensaries statewide, but only a handful were ready for business on the first day: The Botanist (Canton, Ohio), The Forest Sandusky (Sandusky, Ohio), CY+ (Wintersville, Ohio), and Ohio Valley Natural Relief LLC (Wintersville, Ohio). A fifth location (The Botanist, Wickliffe, Ohio) will reportedly open later in the week (1,2).
Ohio’s medical cannabis program has taken two years to get off the ground. Registered patients will be allowed to purchase a 90-day supply, but shortages are expected in the early stages of the launch. Patients will need to show a state-issued i.d. and registry card and pay in cash.
Qualifying conditions for medical cannabis in Ohio reportedly include: AIDS, amyotrophic lateral sclerosis, Alzheimer’s disease, cancer, chronic traumatic encephalopathy, Crohn’s disease, epilepsy or other seizure disorders, fibromyalgia, glaucoma, hepatitis C, inflammatory bowel disease, multiple sclerosis, chronic pain (as well as severe or intractable pain), Parkinson’s disease, positive status for HIV, post-traumatic stress disorder, sickle cell anemia, spinal cord disease or injury, Tourette’s syndrome, traumatic brain injury, and ulcerative colitis (2).
House Budget Bill Amendment Could End Veterans Affairs Medical Cannabis Ban
July 14th 2025The “Big, Beautiful Bill” signed recently into law by President Donald Trump, includes an amendment that may end the medical cannabis ban in the VA which has prevented doctors from recommending the plant to their patients.
Best of the Week: July 4 – July 10, 2025
July 11th 2025Here, we bring you our top five recent articles covering revoking medical cannabis cards in Florida, testing and sampling initiative in Missouri, our mid-year regulations roundup, depenalization ordinance stopped in Texas, and accuracy in THC labeling in flower versus concentrates.
Best of the Week: June 13 – June 19, 2025
June 20th 2025Here, we bring you our top five recent articles covering medical cannabis in Hawaii, a new dispensary in Connecticut, pesticide testing in California, a cease-and-desist letter to a dispensary on Long Island, and a global survey on cannabis for endometriosis.
Global Survey Examines Cannabis Use over Pharmaceuticals for Endometriosis Symptom Relief
June 17th 2025A survey of nearly 900 endometriosis patients across 28 countries highlights cannabis as a preferred alternative to pharmaceuticals, despite legal, social, and medical communication barriers.